Skip to main content
Frontiers in Pediatrics logoLink to Frontiers in Pediatrics
. 2024 Oct 21;12:1315115. doi: 10.3389/fped.2024.1315115

Prediction values of fat-soluble vitamin of growth retardation in children aged 1–6 years

Qingqing Yan 1, Qingwen Zhu 1, Chen Jiang 2, Lingli Zhang 3, Xiaojing Xu 3,*
PMCID: PMC11532041  PMID: 39497736

Abstract

Background

Retardation among children is a persistent global health concern. Vitamin deficiency in childhood may contribute to growth retardation; however, its causal effects are not fully understood.

Objective

Here, we aimed to explore the prediction values of fat-soluble vitamin levels on GR in children aged 1–6 years.

Methods

614 children aged from 1 to 6 years at Nantong Maternal and Child Care Health Hospital between January 2021 and December 2022 in this retrospective observational study participated in the assessment of developmental status and blood detection of vitamin from peripheral blood (PB). The relationship between vitamin levels and GR was analyzed by Multivariable logistic regression analysis.

Results

Developmental assessment results showed that 132 cases from 614 with growth retardation (21.50%). Statistical analysis showed children with GR were more likely to be males (59.45% vs. 40.55%, p = 0.191). The age of children with GR was significantly higher than those without GR (p < 0.01). Importantly, the levels of various fat-soluble vitamins in GR individuals were significantly lower than those in normal individuals. ROC analysis showed that vitamin E, vitamin A and 25(OH) D3 were less effective in predicting GR model (AUC: 0.87, 0.74, and 0.65,). However, the combination of vitamin E, vitamin A and 25(OH)D3 with age was effective in predicting GR. (AUC: 0.84, 0.77, 0.75).

Conclusion

The combination of 25(OH)D3, Vitamin E, Vitamin A with age may have good predictive performance for children GR aged 1–6 years.

Keywords: growth retardation, children, fat-soluble vitamins, vitamin deficiency, prediction value, retrospective observational study

Introduction

Growth retardation (GR) characterized by short stature, low weight, and distinctive facial features is a prevalent disease among children (1). GR is divided into intrauterine growth retardation (IUGR) and extrauterine growth retardation (EUGR). IUGR is defined as a birth weight of newborns below the 10th percentile or two standard deviations of the average weight for the same age (2). While, EUGR defines the growth and development of a newborn after birth, meaning that its growth indicators at all stages are consistently below the 10th percentile level of the expected value (3). Research indicates that IUGR is closely linked to genetic factors, individual variability, and nutritional status both pre-pregnancy and during pregnancy (4). Conversely, EUGR is more significantly influenced by postnatal factors, encompassing both heredity and nutrition (5, 6). While the prevention of EUGR may seem relatively more straightforward than that of IUGR, the multifaceted nature of its influencing factors (including age, nutritional levels, gender et al.,) can lead to misdiagnosis in the professional assessment of GR in children. To truly control childhood GR, integrating various factors into a precise predictive model to develop an effective prevention strategy urgent and necessary.

Despite significant advancements in neonatal care and treatment, the incidence of GR has shown an increasing trend in recent years. In 2010, a staggering 56.70% of children under the age of five (approximately 171.4 million) were suffered from GR worldwide. The prevalence of GR is especially high in regions such as South Asia, Central Asia, and sub-Saharan Africa 0 (7). For instance, in Bangladesh, 36% of children under five years old suffer from stunted growth (8), Meanwhile, in some parts of China, the incidence of GR has climbed to 7.84%. Collectively, GR of children remains a significant global health challenge (9, 10).

Soliman (11) and Verma (12) asserted that chronic nutritional deficiencies, rooted in inadequate long-term nutrient intake, significantly contribute to stunted growth—a viewpoint also endorsed by Black (13, 14). In 2019, to address the global issue of children GR, the World Health Organization (WHO) prioritized enhancing maternal and child nutrition management (15, 16). Fat-soluble vitamins, indispensable for human health, play pivotal roles in growth, development, and immune regulation. The intake disparities of fat-soluble vitamins, whether insufficiency or excess, can result in GR or other diseases. Current research underscores the critical role of vitamins A, D, and E in the embryonic development of bones, muscles, and the nervous system. Supplementing with vitamins D3 and K can facilitate bone development, and sustains calcium homeostasis. Chen C's (17) study indicated that elevated vitamin D levels in late pregnancy may mitigate the risk of GR in children. Despite the involvement of most fat-soluble vitamins in growth regulation and metabolism, the causal link between these vitamins and growth retardation is yet to be conclusively established. Nonetheless, considering the functions of fat-soluble vitamins, it is plausible to hypothesize a correlation between their levels and the incidence of GR.

In this study, we performed developmental assessment and detection of vitamin in peripheral blood in children aged 1–6 years, which aimed to establish a model for vitamin deficiency to predict GR in children by regression analysis.

Methods

Ethics statement

This study was approved by the Ethics Committee of Nantong Maternal and Child Care Health Hospital Affiliated to Nantong University, China. The parents of the children were informed about this study and provided informed consent (Y2020088).

Sample collection

This retrospective observational study enrolled children aged 1–6 years at the Nantong Maternal and Child Care Health Hospital Affiliated to Nantong University, China, between January 2021 and December 2022. Data were extracted from the medical records of the patients, including sex and age.

Study design and sample selection

The inclusion criteria were as follows: (1) participants aged 1–6 years old; (2) GR diagnosis confirmed by clinical, laboratory, and imaging examinations; (3) no systemic medication and psychotherapy administered for GR.

The exclusion criteria were as follows: (1) A history of premature birth, low birth weight, or intrauterine growth restriction; (2) congenital or acquired organ or tissue deficiency disease; (3) presence of respiratory, digestive, urinary, blood, or endocrine factors that may affect growth and development; (4) mental or nervous system diseases resulting in hearing and speech difficulties or inability to cooperate with the study; (5) hereditary growth retardation; (6) incomplete clinical data.

Vitamin detection in peripheral blood by LC-MS/MS

Peripheral blood samples (3 ml) of each participant for vitamin detection were collected prior to eating on the day of the test. The concentrations of Vitamin A, 25-Dihydroxy vitamin D2 [25(OH)D2], 25(OH)D3, Vitamin E and Vitamin K1 were determined using liquid chromatography-mass spectroscopy/mass spectroscopy (LC-MS/MS) analysis by Ultra-high-performance liquid chromatography (Waters Acquisition, USA) and triple four-bar mass spectrometry (XEVO TQD, USA).

Bioinformatic analysis

The Chi-square test was employed to analyze the correlation between various factors and children GR (Table 1); the relationship between vitamins (A, D3, E) and children GR was explored through covariance analysis, with age and gender designated as covariates (Table 3). A binary logistic multivariate analysis was conducted on vitamins (A, D3, E) and age. The Receiver Operating Characteristic (ROC) curve analysis was utilized to determine the Area Under the Curve (AUC) values and to evaluate the predictive values. The Youden Index was applied to ascertain the threshold, with a two-sided p-value less than 0.05 indicating statistical significance. The state variable value was set for the normal control group, and the test variables were vitamins (A, D, E) and age (Table 4).

Table 1.

Comparison of general data.

Variables Growth retardation Normal development x2 p-value
(n = 132) (n = 482)
Child factors
Age (year)
≥1, ≤3 25 (18.90) 261 (54.10) 51.63 <0.01
>3, ≤6 107 (81.1) 221 (45.9)
Sex (%)
Male 85 (64.4) 280 (58.1) 1.71 0.191
Female 47 (35.6) 202 (41.9)
Local area (%)
Nantong local area 106 (80.3) 368 (76.3) 0.92 0.337
Not in the local area 26 (19.7) 114 (23.7)
Parental factors
Educational level (%)
Bachelor's degree or above 45 (34.1) 148 (30.7) 0.55 0.458
Below bachelor's degree 87 (65.9) 334 (69.3)
Mother's gestational age (%)
35 years old or older 18 (13.6) 78 (16.2) 0.46 0.521
Under 35 years old 114 (86.4) 404 (83.8)
Pregnancy related diseases (%)
Pregnancy complicated with diabetes 13 (9.8) 38 (7.9) 0.53 0.469
Normal pregnancy 119 (90.2) 444 (92.1)
Pregnancy complicated with anemia 10 (7.6) 42 (8.7) 0.17 0.677
Normal pregnancy 122 (92.4) 440 (91.3)
Pregnancy complicated with thyroid disease 8 (6.1) 46 (9.5) 0.53 0.469
Normal pregnancy 124 (93.9) 436 (90.5)
Method of conception (%)
Unnatural conception 3 (2.3) 31 (6.4) 3.43 0.064
Nature conceived 129 (97.7) 451 (93.6)

Table 3.

Multivariable logistic regression analysis.

Index OR 95% CI B-value p-value
Lower limit Superior limit
Age 0.104 0.060 0.179 −2.265 <0.01
Vitamin A 2.318 1.232 4.358 0.841 <0.01
25(OH)D3 2.802 1.610 4.876 1.030 <0.01
Vitamin E 1.307 1.001 1.869 0.752 0.042
Vitamin K1 0.468 0.157 1.396 −0.759 0.173

CI, confidence interval; OR, odds ratio; B value: The regression coefficient and intercept.

Table 4.

prediction performance.

Variable AUC p-value 95% CI Cut off value Sensitivity Specificity Youden index
Lower limit Superior limit
Vitamin A 0.74 <0.01 0.70 0.79 252.45 0.68 0.72 0.40
25(OH)D3 0.65 <0.01 0.60 0.70 23.28 0.56 0.70 0.26
Vitamin E 0.87 <0.01 0.85 0.90 4.77 0.74 0.91 0.65
Age and vitamin A combination 0.77 <0.01 0.73 0.82 / 0.83 0.64 0.48
Age and 25(OH)D3 combination 0.75 <0.01 0.70 0.80 / 0.80 0.66 0.46
Age and vitamin E combination 0.84 <0.01 0.80 0.87 / 0.79 0.80 0.59
Combination 0.88 <0.01 0.84 0.90 / 0.85 0.76 0.61

CI, confidence interval; AUC, area under curve.

Statistical analysis

The significance of between-group differences was assessed using Covariance analysis with SPSS (version 26.0; SPSS Inc., Chicago, IL, USA). Normally distributed continuous data are presented as the mean ± SD. Skewed distributed continuous data are presented as median (range) and were compared using the Mann-Whitney U-test. Categorical data are described as n (%) and were compared between groups using the chi-squared test.

Results

Overview of the survey

614 form 1,000 children aged 1–6 years old were determined to meet the selection criteria. Ultimately, 132 of 614 children were identified as GR based on body condition assessments (Figure 1). The results of statistical analysis found that, children with GR were more likely to be males compared to children without GR (p = 0.191). There was also a difference in age between the two groups, which showed that children with GR are older than those without GR. Importantly, in the GR sample, GR was more likely to occur in individuals aged 4–6 years compared to individuals aged 1–3 years (p < 0.01). At the same time, we also paid attention to the influence of other factors on children's GR, and the results showed that: the factors such as Local area, Parental factors, Mother's gestational age, Pregnancy related diseases, Mother's gestational age are not the main factors for GR in children (Table 1).

Figure 1.

Figure 1

Incorporate into the research flowchart.

Vitamin content comparison in children with GR or not

Next, we compared the difference of different fat-soluble vitamins in children with GR or not by controlling Gender and age factors via covariance analysis. The results showed that the level of vitamin A, D and E in children with GR is significantly lower than that in children without GR. For the detail: Vitamin A (230.35 ± 66.01 vs. 289.19 ± 70.28, p < 0.01), 25(OH)D3 (23.95 ± 7.30 vs. 27.91 ± 7.91, p < 0.01), Vitamin E (4.37 ± 1.77 vs. 7.03 ± 1.92, p < 0.01) (Table 2).

Table 2.

Comparison of vitamin indexes data.

Variables Growth retardation Normal development F/Z p-value
(n = 132) (n = 482)
Vitamin A (ng/ml) 230.35 ± 66.01 289.19 ± 70.28 20.196 <0.01
25(OH)D3 (ng/ml) 23.95 ± 7.3 27.91 ± 7.91 16.733 <0.01
Vitamin E (µg/ml) 4.37 ± 1.77 7.03 ± 1.92 61.237 <0.01
25(OH)D2 (ng/ml) 0.30, (0.86,0.62) 0.28, (0.82,0.42) 0.126 0.776
Vitamin K1 (ng/ml) 0.22 (0.84,0.42) 0.41, (1.14,0.70) −5.043 <0.01

Multivariable logistic regression analysis

Meanwhile, we analyzed the relationship between different factors (age and vitamin level) and GR by Multivariable logistic regression analysis. The results revealed that age (OR = 0.104, 95% CI: 0.06–0.179, p < 0.01), Vitamin A (OR = 2.318, 95% CI: 1.232, 4.358, p < 0.05), Vitamin E (OR = 1.307, 95% CI: 1.001–1.869, p < 0.05), and 25(OH)D3 (OR = 2.802, 95% CI: 1.610–4.876, p < 0.05) were independent risk factors for GR (Table 3). The AUC of Vitamin E, Vitamin A,25(OH)D3, for predicting GR were 0.87, 0.74 and 0.65, respectively. However, the combination of Vitamin E, Vitamin A, 25(OH)D3 and age in predicting GR had an AUC of 0.88 (95% CI:0.84–0.90) (Figure 2, Table 4).

Figure 2.

Figure 2

ROC curve for predicting growth retardation.

Discussion

In this study, we examined the correlation between various factors (including maternal educational background, pregnancy-related diseases, gender, and age) and the incidence of children GR. Our findings revealed that GR in children is significantly associated with age, with the condition predominantly manifesting between 4 and 6 years of age. This observation aligns with the points of Nshimyiryoh (18) and Kismul (19). Children older than 3 years exhibit a notably higher risk of GR. Consequently, particular attention should be directed towards preschool children aged between 3 and 6, as this period represents a critical phase of rapid growth and development, particularly for bones and muscles (20).

Physical growth and neural cell development are crucial for early childhood. Vitamins play a vital role in cell formation, bone growth, and other bodily functions for growth (21). Many fat-soluble vitamins, especially 25(OH)D, can regulate calcium and phosphorus metabolism (2224) during bone and brain development (Figure 3) (2527). According to an epidemiological survey, 1 billion people worldwide suffer from vitamin D deficiency or insufficiency (28, 29), and children in the growth stage are most vulnerable to its effects (30). The rate of 25(OH)D deficiency in children under 3 years of age is only 7.1%, which is 75% in children over 3 years of age (31). In this study, children with growth retardation had significantly lower 25(OH)D3 levels than those with normal development, reflecting the significance of 25(OH)D3 deficiency and its impact on growth retardation in children age 1–6 years.

Figure 3.

Figure 3

Effects of fat-soluble vitamins on body growth and development.

Adequate amounts of vitamins A, E, and 25(OH)D3 are essential for growth promotion and protection. Adequate Vitamin A intake during delivery enhances the outcomes of newborns and promotes neural development in later childhood (32). Vitamin E deficiency can cause neural degeneration, atrophy, and purkinje cell death, leading to spinocerebellar ataxia, particularly during embryonic and early childhood neural development (Figure 3) (3335). In this study, Vitamin A levels were significantly different between the two groups of children; Vitamin E levels were lower in the observation group. Combined with the results of Ernawati et al., we conclude that fat-soluble vitamin deficiency is not only the main cause of GR in children, but also may be the main reasons for the cognitive and neurodevelopmental delays observed in most of the children.

Despite the promising results and key findings, this study has some limitations. First, it was conducted in only one hospital, and the sample size was relatively small. Therefore, the findings of this study may not be applicable to other populations or settings. Second, the study only included children receiving treatment at the selected hospital, which may have led to selection bias. Third, the study did not control for potential confounding variables such as dietary intake, which could have influenced the findings.

Acknowledgments

We would like to thank the staff of Maternal and Child Health Care Hospital of Nantong, Affiliated Hospital of Nantong University for their contributions. We also thank Qingqing Yan, Qingwen Zhu, Chen Jiang, Lingli Zhang, Xiaojing Xu for their efforts as field researchers and Qingqing Yan for his statistical expertise.

Funding Statement

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by Ethics Committee of Nantong Maternal and Child Health Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin. Written informed consent was obtained from the minor(s)' legal guardian/next of kin for the publication of any potentially identifiable images or data included in this article.

Author contributions

QY: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Writing – original draft, Writing – review & editing. QZ: Conceptualization, Data curation, Formal Analysis, Investigation, Validation, Writing – review & editing. CJ: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Supervision, Writing – review & editing. LZ: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Writing – review & editing. XX: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Software, Supervision, Validation, Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.Leroy JL, Frongillo EA. Perspective: what does stunting really mean? A critical review of the evidence. Adv Nutr. (2019) 10(2):196–204. 10.1093/advances/nmy101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mohammad N, Sohaila A, Rabbani U, Ahmed S, Ahmed S, Ali SR. Maternal predictors of intrauterine growth retardation. J Coll Physicians Surg Pak. (2018) 28(9):681–5. 10.29271/jcpsp.2018.09.681 [DOI] [PubMed] [Google Scholar]
  • 3.Zhao T, Feng HM, Caicike B, Zhu YP. Investigation into the current situation and analysis of the factors influencing extrauterine growth retardation in preterm infants. Front Pediatr. (2021) 9:643387. 10.3389/fped.2021.643387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Yang L, Feng L, Huang L, Li X, Qiu W, Yang K, et al. Maternal factors for intrauterine growth retardation: systematic review and meta-analysis of observational studies. Reprod Sci. (2023) 30(6):1737–45. 10.1007/s43032-021-00756-3 [DOI] [PubMed] [Google Scholar]
  • 5.Suratri MAL, Putro G, Rachmat B, Nurhayati, Ristrini, Pracoyo NE, et al. Risk factors for stunting among children under five years in the province of east nusa tenggara (NTT), Indonesia. Int J Environ Res Public Health. (2023) 20(2):1640. 10.3390/ijerph20021640 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lees CC, Stampalija T, Baschat A, da Silva Costa F, Ferrazzi E, Figueras F, et al. ISUOG practice guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. (2020) 56(2):298–312. 10.1002/uog.22134 [DOI] [PubMed] [Google Scholar]
  • 7.Bhutta ZA, Salam RA. Global nutrition epidemiology and trends. Ann Nutr Metab. (2012) 61(Suppl 1):19–27. 10.1159/000345167 [DOI] [PubMed] [Google Scholar]
  • 8.Akram R, Sultana M, Ali N, Sheikh N, Sarker AR. Prevalence and determinants of stunting among preschool children and its urban-rural disparities in Bangladesh. Food Nutr Bull. (2018) 39(4):521–35. 10.1177/0379572118794770 [DOI] [PubMed] [Google Scholar]
  • 9.Heidkamp RA, Piwoz E, Gillespie S, Keats EC, D'Alimonte MR, Menon P, et al. Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the sustainable development goals: an agenda for action. Lancet. (2021) 397(10282):1400–18. 10.1016/S0140-6736(21)00568-7 [DOI] [PubMed] [Google Scholar]
  • 10.Victora CG, Christian P, Vidaletti LP, Gatica-Domínguez G, Menon P, Black RE. Revisiting maternal and child undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda. Lancet. (2021) 397(10282):1388–99. 10.1016/S0140-6736(21)00394-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.De Sanctis V, Soliman A, Alaaraj N, Ahmed S, Alyafei F, Hamed N. Early and long-term consequences of nutritional stunting: from childhood to adulthood. Acta Biomed. (2021) 92(1):e2021168. 10.23750/abm.v92i1.11346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Verma P, Prasad JB. Stunting, wasting and underweight as indicators of under-nutrition in under five children from developing countries: a systematic review. Diabetes Metab Syndr. (2021) 15(5):102243. 10.1016/j.dsx.2021.102243 [DOI] [PubMed] [Google Scholar]
  • 13.Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. (2008) 371(9608):243–60. 10.1016/S0140-6736(07)61690-0 [DOI] [PubMed] [Google Scholar]
  • 14.Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. (2013) 382(9890):427–51. 10.1016/S0140-6736(13)60937-X Erratum in: Lancet. 2013. 2013 August 3;382(9890):396. [DOI] [PubMed] [Google Scholar]
  • 15.WHO; UNICEF. The Extension of the 2025 Maternal, Infant and Young Child Nutrition Targets to 2030. Volume 12. Geneva, Switzerland: World Health Organization; (2019). [Google Scholar]
  • 16.WHO. World Health Statistics SDGs. Volume 130. Geneva, Switzerland: World Health Organization; (2016). [Google Scholar]
  • 17.Chen C, Zhou C, Zhang J, Tian Y, Wang X, Jiao X, et al. Associations between longitudinal maternal and cord blood vitamin D Status and child growth trajectories up to 4 years of age. Nutrients. (2024) 16(15):2410. 10.3390/nu16152410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nshimyiryo A, Hedt-Gauthier B, Mutaganzwa C, Kirk CM, Beck K, Ndayisaba A, et al. Risk factors for stunting among children under five years: a cross-sectional population-based study in Rwanda using the 2015 demographic and health survey. BMC Public Health. (2019) 19(1):175. 10.1186/s12889-019-6504-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kismul H, Acharya P, Mapatano MA, Hatløy A. Determinants of childhood stunting in the democratic Republic of Congo: further analysis of demographic and health survey 2013–14. BMC Public Health. (2017) 18(1):74. 10.1186/s12889-017-4621-0. Erratum in: BMC Public Health. 2017 September 22;17(1):736. doi: 10.1186/s12889-017-4709-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sen P, Bharati S, Som S, Pal M, Bharati P. Growth and nutritional status of preschool children in India: a study of two recent time periods. Food Nutr Bull. (2011) 32(2):84–93. 10.1177/156482651103200202 [DOI] [PubMed] [Google Scholar]
  • 21.Yee MMF, Chin KY, Ima-Nirwana S, Wong SK. Vitamin A and bone health: a review on current evidence. Molecules. (2021) 26(6):1757. 10.3390/molecules26061757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ursem SR, Vervloet MG, Büttler RM, Ackermans MT, Oosterwerff MM, Eekhoff EMV, et al. The interrelation between FGF23 and glucose metabolism in humans. J Diabetes Complications. (2018) 32(9):845–50. 10.1016/j.jdiacomp.2018.06.013 [DOI] [PubMed] [Google Scholar]
  • 23.Charoenngam N, Shirvani A, Holick MF. Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma. (2019) 10(6):1082–93. 10.1016/j.jcot.2019.07.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Goltzman D. Functions of vitamin D in bone. Histochem Cell Biol. (2018) 149(4):305–12. 10.1007/s00418-018-1648-y [DOI] [PubMed] [Google Scholar]
  • 25.Gáll Z, Székely O. Role of vitamin D in cognitive dysfunction: new molecular concepts and discrepancies between animal and human findings. Nutrients. (2021) 13(11):3672. 10.3390/nu13113672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases: a rationale for a pathogenic impact. Int J Mol Sci. (2018) 19(8):2245. 10.3390/ijms19082245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Siracusano M, Riccioni A, Abate R, Benvenuto A, Curatolo P, Mazzone L. Vitamin D deficiency and autism Spectrum disorder. Curr Pharm Des. (2020) 26(21):2460–74. 10.2174/1381612826666200415174311 [DOI] [PubMed] [Google Scholar]
  • 28.Blakeley CE, Van Rompay MI, Schultz NS, Sacheck JM. Relationship between muscle strength and dyslipidemia, serum 25(OH)D, and weight status among diverse schoolchildren: a cross-sectional analysis. BMC Pediatr. (2018) 18(1):23. 10.1186/s12887-018-0998-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Christie FT, Mason L. Knowledge, attitude and practice regarding vitamin D deficiency among female students in Saudi Arabia: a qualitative exploration. Int J Rheum Dis. (2011) 14(3):e22–9. 10.1111/j.1756-185X.2011.01624.x [DOI] [PubMed] [Google Scholar]
  • 30.Rajah J, Jubeh JA, Haq A, Shalash A, Parsons H. Nutritional rickets and z scores for height in the United Arab Emirates: to D or not to D? Pediatr Int. (2008) 50(4):424–8. 10.1111/j.1442-200X.2008.02700.x [DOI] [PubMed] [Google Scholar]
  • 31.Drali O, Arab M, Lamdjadani N, Guechi Z, Berrah H. Vitamin D status in preschool children in Algeria. Arch Pediatr. (2021) 28(3):215–21. 10.1016/j.arcped.2020.12.013 [DOI] [PubMed] [Google Scholar]
  • 32.Zhang X, Chen K, Wei XP, Qu P, Liu YX, Chen J, et al. Perinatal vitamin A status in relation to neurodevelopmental outcome at two years of age. Int J Vitam Nutr Res. (2009) 79(4):238–49. 10.1024/0300-9831.79.4.238 [DOI] [PubMed] [Google Scholar]
  • 33.Traber MG. Vitamin E: necessary nutrient for neural development and cognitive function. Proc Nutr Soc. (2021) 80(3):319–26. 10.1017/S0029665121000914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life. (2019) 71(4):487–94. 10.1002/iub.1976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jung JB, Kim Y, Oh K, Kim SA, Doh JH, Oh HJ, et al. Subacute combined degeneration associated with vitamin E deficiency due to small bowel obstruction: a case report. Medicine (Baltimore). (2019) 98(36):e17052. 10.1097/MD.0000000000017052 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.


Articles from Frontiers in Pediatrics are provided here courtesy of Frontiers Media SA

RESOURCES